Studies on a circulating anticoagulant inhibiting factor XI in a patient with congenital deficiency and carcinoma of the prostate.

@article{Chediak1986StudiesOA,
  title={Studies on a circulating anticoagulant inhibiting factor XI in a patient with congenital deficiency and carcinoma of the prostate.},
  author={J. Alexander Chediak and P Madej-Zevin and Oscar D. Ratnoff and George H Goldsmith and B Everson},
  journal={British journal of haematology},
  year={1986},
  volume={63 1},
  pages={123-33}
}
An inhibitor of plasma thromboplastin antecedent (PTA, factor XI), measured in coagulant and radioimmunoassays, was detected in a 60-year-old man with carcinoma of the prostate who had no evidence of a bleeding tendency. Family studies indicated that the patient was either a homozygote or a heterozygote for hereditary factor XI deficiency. In contrast to… CONTINUE READING